In-Depth Analysis of the Interaction of HIV-1 with Cellular microRNA Biogenesis and Effector Mechanisms
The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4 + peripher...
Saved in:
| Published in | mBio Vol. 4; no. 2; p. e000193 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society of Microbiology
01.05.2013
American Society for Microbiology |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4
+
peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites.
IMPORTANCE
MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. |
|---|---|
| AbstractList | The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites.
MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. ABSTRACT The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4+ peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4 + peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites.UNLABELLEDThe question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites.MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.IMPORTANCEMicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4 + peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4 ⁺ peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms. |
| Author | Whisnant, Adam W. Ho, Phong Stevenson, Mario Chen, Chin-Ho Sharova, Natalia Powers, Jason G. Cullen, Bryan R. Flores, Omar Bogerd, Hal P. |
| Author_xml | – sequence: 1 givenname: Adam W. surname: Whisnant fullname: Whisnant, Adam W. organization: Department of Molecular Genetics & Microbiology and the Center for Virology, Duke University Medical Center, Durham, North Carolina, USA – sequence: 2 givenname: Hal P. surname: Bogerd fullname: Bogerd, Hal P. organization: Department of Molecular Genetics & Microbiology and the Center for Virology, Duke University Medical Center, Durham, North Carolina, USA – sequence: 3 givenname: Omar surname: Flores fullname: Flores, Omar organization: Department of Molecular Genetics & Microbiology and the Center for Virology, Duke University Medical Center, Durham, North Carolina, USA – sequence: 4 givenname: Phong surname: Ho fullname: Ho, Phong organization: Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA – sequence: 5 givenname: Jason G. surname: Powers fullname: Powers, Jason G. organization: Department of Molecular Genetics & Microbiology and the Center for Virology, Duke University Medical Center, Durham, North Carolina, USA – sequence: 6 givenname: Natalia surname: Sharova fullname: Sharova, Natalia organization: Division of Infectious Diseases, Department of Medicine, University of Miami, School of Medicine, Miami, Florida, USA – sequence: 7 givenname: Mario surname: Stevenson fullname: Stevenson, Mario organization: Division of Infectious Diseases, Department of Medicine, University of Miami, School of Medicine, Miami, Florida, USA – sequence: 8 givenname: Chin-Ho surname: Chen fullname: Chen, Chin-Ho organization: Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA – sequence: 9 givenname: Bryan R. surname: Cullen fullname: Cullen, Bryan R. organization: Department of Molecular Genetics & Microbiology and the Center for Virology, Duke University Medical Center, Durham, North Carolina, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23592263$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkkFv1DAQhSNUREvpkSvKkUuKx47t5IK0LIVGKiAh4Go5znjXVWIvdhbUf4_TbRFFSPji0fjNpye_eVoc-eCxKJ4DOQegzavpjQvnhEDLKmCPihMKnFSSAxwttYCKAm2Pi7OUrkk-jEHDyJPimDLeUirYSbHpfPUWd_O2XHk93iSXymDLeYtl52eM2swu-KV12X2roPzpsnKN47gfdSwnZ2L4_HFVZhsb9LhMaz-UF9aimUMsP6DZau_SlJ4Vj60eE57d3afF13cXX9aX1dWn9916dVWZuhFzJSjKmuIgdC8bC5w1IHsqmpYKQnPBLaftAFCjkRoG5D1wrlnTyqE3kiM7LboDdwj6Wu2im3S8UUE7ddsIcaN0nJ0ZUTWWAC58YtsaWtJQkJZoImsLgvUL6_WBtdv3Ew4G_Rz1-AD68MW7rdqEH4oJVgsiM-DlHSCG73tMs5pcMvn3tMewTwpkLRivCan_L2W04XUWL9QXf9r67ec-1CxgB0FOJ6WIVhk36yXI7NKNCohatkct26Nutyfj81T119Q9-N_6XyObxF0 |
| CitedBy_id | crossref_primary_10_1038_srep28279 crossref_primary_10_3390_ncrna11010008 crossref_primary_10_1038_s41537_023_00340_5 crossref_primary_10_1016_j_coviro_2013_09_003 crossref_primary_10_1007_s00705_017_3305_5 crossref_primary_10_1016_j_cois_2014_12_008 crossref_primary_10_15252_embj_201694335 crossref_primary_10_1016_j_omtn_2019_06_006 crossref_primary_10_3390_v15041027 crossref_primary_10_1186_gb_2014_15_1_r2 crossref_primary_10_4137_BMI_S29512 crossref_primary_10_2217_fvl_14_17 crossref_primary_10_1371_journal_pone_0187973 crossref_primary_10_3390_ncrna5010007 crossref_primary_10_3892_ijmm_2025_5494 crossref_primary_10_1016_j_chom_2019_07_005 crossref_primary_10_3390_v10030110 crossref_primary_10_1128_mBio_01038_20 crossref_primary_10_3390_cells10092425 crossref_primary_10_1177_1759091419850983 crossref_primary_10_1038_srep25341 crossref_primary_10_1038_s41598_019_41978_5 crossref_primary_10_1016_S2055_6640_20_30322_8 crossref_primary_10_1146_annurev_virology_031413_085439 crossref_primary_10_1038_s41467_017_01954_x crossref_primary_10_1038_s41598_019_39220_3 crossref_primary_10_3390_ijms24010617 crossref_primary_10_1002_wrna_1186 crossref_primary_10_1093_nar_gkw167 crossref_primary_10_1080_1354750X_2022_2163694 crossref_primary_10_1186_s12977_024_00637_y crossref_primary_10_1097_COH_0000000000000135 crossref_primary_10_3390_ijms22147658 crossref_primary_10_3390_ijms19041217 crossref_primary_10_3389_fgene_2019_01104 crossref_primary_10_1093_nar_gkw1289 crossref_primary_10_1016_j_jmb_2013_12_017 crossref_primary_10_1186_s12977_018_0403_8 crossref_primary_10_1016_j_gene_2017_01_018 crossref_primary_10_1038_cdd_2017_99 crossref_primary_10_1016_j_ebiom_2021_103338 crossref_primary_10_1016_j_ijcard_2016_09_010 crossref_primary_10_3390_ijms17040538 crossref_primary_10_1038_s41467_018_06046_y crossref_primary_10_3389_fgene_2015_00108 crossref_primary_10_1021_acs_molpharmaceut_8b00880 crossref_primary_10_1128_mBio_02125_16 crossref_primary_10_1261_rna_059345_116 crossref_primary_10_3390_antiox12040800 crossref_primary_10_1186_s12859_016_0964_2 crossref_primary_10_1186_1742_4690_10_95 crossref_primary_10_1016_j_virol_2014_02_009 crossref_primary_10_3892_ijmm_2024_5344 crossref_primary_10_3389_fimmu_2022_1091543 crossref_primary_10_1371_journal_pone_0164644 crossref_primary_10_1038_s41598_020_60073_8 crossref_primary_10_1186_s41544_020_00056_z crossref_primary_10_3390_biomedicines10061408 crossref_primary_10_3390_genes15050574 crossref_primary_10_1021_acsnano_1c03242 crossref_primary_10_1186_s12977_015_0205_1 crossref_primary_10_1177_1753425916661042 crossref_primary_10_1016_j_virusres_2015_07_023 crossref_primary_10_1016_j_jdiacomp_2021_108021 crossref_primary_10_1002_2211_5463_12952 crossref_primary_10_3892_ijmm_2020_4626 crossref_primary_10_3389_fmolb_2019_00122 crossref_primary_10_1038_mtna_2014_67 crossref_primary_10_1371_journal_ppat_1003694 crossref_primary_10_1371_journal_pone_0132127 crossref_primary_10_3389_fgene_2023_1216890 crossref_primary_10_1016_j_celrep_2017_09_030 crossref_primary_10_1016_j_jns_2016_06_046 crossref_primary_10_1016_j_jneuroim_2017_01_016 crossref_primary_10_1093_nar_gkt1291 crossref_primary_10_1002_rmv_1881 crossref_primary_10_1097_COH_0000000000000089 crossref_primary_10_1155_2020_1561278 crossref_primary_10_1155_2018_7305380 crossref_primary_10_3748_wjg_v21_i24_7375 crossref_primary_10_1016_j_coviro_2014_03_013 crossref_primary_10_1080_15476286_2015_1014759 crossref_primary_10_1128_JVI_03587_13 crossref_primary_10_1038_s41598_020_69799_x crossref_primary_10_1016_j_jhep_2014_10_004 crossref_primary_10_3389_fmicb_2018_03185 crossref_primary_10_1007_s00210_024_03198_1 crossref_primary_10_1371_journal_ppat_1005588 crossref_primary_10_3390_cancers16233962 crossref_primary_10_1111_hiv_12822 crossref_primary_10_3390_v16071076 crossref_primary_10_1042_BST20160100 crossref_primary_10_1016_j_cellsig_2023_110845 crossref_primary_10_1002_bies_201300150 crossref_primary_10_3390_biomedicines9111627 crossref_primary_10_1074_jbc_M115_662171 crossref_primary_10_1002_wrna_1308 crossref_primary_10_3390_diagnostics10040228 crossref_primary_10_1186_s12865_020_00386_5 crossref_primary_10_1128_jvi_00652_23 crossref_primary_10_1016_j_virusres_2018_08_018 crossref_primary_10_2174_1570162X16666180219155324 crossref_primary_10_1371_journal_pone_0187310 crossref_primary_10_1128_JVI_01566_15 crossref_primary_10_1038_s41375_018_0015_2 crossref_primary_10_1152_physiolgenomics_00112_2013 crossref_primary_10_3389_fonc_2018_00450 crossref_primary_10_1007_s12020_023_03673_4 crossref_primary_10_1038_s44318_024_00172_8 crossref_primary_10_1038_s41467_024_52943_w crossref_primary_10_1186_s13578_021_00703_4 crossref_primary_10_1038_nrmicro_2017_60 crossref_primary_10_1038_s41564_022_01264_z crossref_primary_10_2217_fvl_13_59 crossref_primary_10_1109_TCBB_2019_2910851 |
| Cites_doi | 10.1016/j.molcel.2009.06.003 10.1016/j.cell.2009.01.002 10.1186/1742-4690-6-18 10.1128/jvi.59.2.284-291.1986 10.1038/nmeth746 10.1073/pnas.1119873109 10.1038/nrmicro772 10.1093/nar/gkn076 10.1038/nprot.2006.47 10.1126/science.1187197 10.1016/j.cell.2006.03.043 10.1128/mBio.00549-12 10.1146/annurev.micro.112408.134243 10.1016/j.immuni.2005.03.010 10.1128/AAC.46.6.1896-1905.2002 10.1126/science.1136319 10.1016/j.molcel.2012.10.002 10.1016/j.cell.2010.03.009 10.1128/JVI.01390-07 10.1093/nar/gkq1027 10.1371/journal.ppat.1002510 10.1371/journal.ppat.1000057 10.1182/blood-2008-09-175000 10.1186/1742-4690-5-117 10.1038/nmeth.2078 10.1128/JVI.00078-10 10.1073/pnas.88.8.3097 10.1093/nar/gkr961 10.1016/j.chom.2011.09.012 10.1016/j.molcel.2004.12.002 10.1016/j.chom.2012.05.019 10.1128/JVI.00202-10 10.1016/j.virol.2011.01.002 10.1038/nature08237 10.1186/1471-2199-8-63 10.1101/gr.110882.110 10.1101/gad.1522907 10.1126/science.1113329 10.1073/pnas.1114204109 10.1128/JVI.02013-09 10.1371/journal.pone.0017246 10.1038/nm1639 10.1093/nar/gkr991 10.1073/pnas.1116107109 10.1128/JVI.01248-10 10.1186/gb-2011-12-8-r79 10.1093/nar/gkp707 10.1126/science.1905842 10.1074/jbc.M504714200 10.1016/j.chom.2010.12.001 10.1093/nar/gkr719 10.1186/1742-4690-1-44 10.1016/j.virusres.2008.06.008 10.1099/vir.0.80449-0 10.1126/science.3014648 10.1016/0042-6822(83)90395-1 10.1038/nsmb1138 10.1093/nar/gkn805 10.1038/sj.emboj.7600491 |
| ContentType | Journal Article |
| Copyright | Copyright © 2013 Whisnant et al. 2013 Whisnant et al. |
| Copyright_xml | – notice: Copyright © 2013 Whisnant et al. 2013 Whisnant et al. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1128/mBio.00193-13 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) Acceso a contenido Full Text - Doaj |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic AGRICOLA |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| DocumentTitleAlternate | MicroRNA Interactions with HIV-1 |
| EISSN | 2150-7511 |
| ExternalDocumentID | oai_doaj_org_article_8f01e817b0f941908217f0a074f163be PMC3634607 23592263 10_1128_mBio_00193_13 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI065310 – fundername: NCI NIH HHS grantid: T32-CA009111 – fundername: NIAID NIH HHS grantid: P30 AI064518 – fundername: NIMH NIH HHS grantid: U19-MH081836 – fundername: NIMH NIH HHS grantid: U19 MH081836 – fundername: NIAID NIH HHS grantid: P30-AI073961 – fundername: NIAID NIH HHS grantid: P30 AI073961 – fundername: NIAID NIH HHS grantid: U19-AI096109 – fundername: NIAID NIH HHS grantid: U19 AI096109 – fundername: NIAID NIH HHS grantid: 5P30-AI064518 |
| GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAGFI AAUOK AAYXX ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW C1A CITATION DIK E3Z EBS EJD FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 O5R O5S O9- OK1 P2P PGMZT RHI RNS RPM RSF CGR CUY CVF ECM EIF M~E NPM RHF 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c486t-62e742ed6ab78f153817b26892602b265f529d114ec7a1de5b155a3897dbc75e3 |
| IEDL.DBID | M48 |
| ISSN | 2161-2129 2150-7511 |
| IngestDate | Wed Aug 27 01:22:11 EDT 2025 Thu Aug 21 14:05:18 EDT 2025 Fri Jul 11 02:57:50 EDT 2025 Fri Jul 11 08:05:51 EDT 2025 Wed Feb 19 02:31:33 EST 2025 Tue Jul 01 01:52:21 EDT 2025 Thu Apr 24 22:53:39 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c486t-62e742ed6ab78f153817b26892602b265f529d114ec7a1de5b155a3897dbc75e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Editor Stephen Goff, Columbia University |
| OpenAccessLink | https://doaj.org/article/8f01e817b0f941908217f0a074f163be |
| PMID | 23592263 |
| PQID | 1328543547 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8f01e817b0f941908217f0a074f163be pubmedcentral_primary_oai_pubmedcentral_nih_gov_3634607 proquest_miscellaneous_1746354004 proquest_miscellaneous_1328543547 pubmed_primary_23592263 crossref_citationtrail_10_1128_mBio_00193_13 crossref_primary_10_1128_mBio_00193_13 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20130501 |
| PublicationDateYYYYMMDD | 2013-05-01 |
| PublicationDate_xml | – month: 05 year: 2013 text: 20130501 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | mBio |
| PublicationTitleAlternate | mBio |
| PublicationYear | 2013 |
| Publisher | American Society of Microbiology American Society for Microbiology |
| Publisher_xml | – name: American Society of Microbiology – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_60_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_2_2 |
| References_xml | – ident: e_1_3_2_48_2 doi: 10.1016/j.molcel.2009.06.003 – ident: e_1_3_2_2_2 doi: 10.1016/j.cell.2009.01.002 – ident: e_1_3_2_17_2 doi: 10.1186/1742-4690-6-18 – ident: e_1_3_2_28_2 doi: 10.1128/jvi.59.2.284-291.1986 – ident: e_1_3_2_12_2 doi: 10.1038/nmeth746 – ident: e_1_3_2_6_2 doi: 10.1073/pnas.1119873109 – ident: e_1_3_2_42_2 doi: 10.1038/nrmicro772 – ident: e_1_3_2_18_2 doi: 10.1093/nar/gkn076 – ident: e_1_3_2_57_2 doi: 10.1038/nprot.2006.47 – ident: e_1_3_2_37_2 doi: 10.1126/science.1187197 – ident: e_1_3_2_11_2 doi: 10.1016/j.cell.2006.03.043 – ident: e_1_3_2_52_2 doi: 10.1128/mBio.00549-12 – ident: e_1_3_2_8_2 doi: 10.1146/annurev.micro.112408.134243 – ident: e_1_3_2_51_2 doi: 10.1016/j.immuni.2005.03.010 – ident: e_1_3_2_25_2 doi: 10.1128/AAC.46.6.1896-1905.2002 – ident: e_1_3_2_23_2 doi: 10.1126/science.1136319 – ident: e_1_3_2_4_2 doi: 10.1016/j.molcel.2012.10.002 – ident: e_1_3_2_45_2 doi: 10.1016/j.cell.2010.03.009 – ident: e_1_3_2_13_2 doi: 10.1128/JVI.01390-07 – ident: e_1_3_2_58_2 doi: 10.1093/nar/gkq1027 – ident: e_1_3_2_40_2 doi: 10.1371/journal.ppat.1002510 – ident: e_1_3_2_31_2 doi: 10.1371/journal.ppat.1000057 – ident: e_1_3_2_53_2 doi: 10.1182/blood-2008-09-175000 – ident: e_1_3_2_49_2 doi: 10.1186/1742-4690-5-117 – ident: e_1_3_2_22_2 doi: 10.1038/nmeth.2078 – ident: e_1_3_2_41_2 doi: 10.1128/JVI.00078-10 – ident: e_1_3_2_30_2 doi: 10.1073/pnas.88.8.3097 – ident: e_1_3_2_50_2 doi: 10.1093/nar/gkr961 – ident: e_1_3_2_32_2 doi: 10.1016/j.chom.2011.09.012 – ident: e_1_3_2_3_2 doi: 10.1016/j.molcel.2004.12.002 – ident: e_1_3_2_43_2 doi: 10.1016/j.chom.2012.05.019 – ident: e_1_3_2_55_2 doi: 10.1128/JVI.00202-10 – ident: e_1_3_2_7_2 doi: 10.1016/j.virol.2011.01.002 – ident: e_1_3_2_54_2 doi: 10.1038/nature08237 – ident: e_1_3_2_16_2 doi: 10.1186/1471-2199-8-63 – ident: e_1_3_2_47_2 doi: 10.1101/gr.110882.110 – ident: e_1_3_2_21_2 doi: 10.1101/gad.1522907 – ident: e_1_3_2_38_2 doi: 10.1126/science.1113329 – ident: e_1_3_2_36_2 doi: 10.1073/pnas.1114204109 – ident: e_1_3_2_56_2 doi: 10.1128/JVI.02013-09 – ident: e_1_3_2_44_2 doi: 10.1371/journal.pone.0017246 – ident: e_1_3_2_24_2 doi: 10.1038/nm1639 – ident: e_1_3_2_59_2 doi: 10.1093/nar/gkr991 – ident: e_1_3_2_9_2 doi: 10.1073/pnas.1116107109 – ident: e_1_3_2_35_2 doi: 10.1128/JVI.01248-10 – ident: e_1_3_2_46_2 doi: 10.1186/gb-2011-12-8-r79 – ident: e_1_3_2_19_2 doi: 10.1093/nar/gkp707 – ident: e_1_3_2_26_2 doi: 10.1126/science.1905842 – ident: e_1_3_2_34_2 doi: 10.1074/jbc.M504714200 – ident: e_1_3_2_39_2 doi: 10.1016/j.chom.2010.12.001 – ident: e_1_3_2_20_2 doi: 10.1093/nar/gkr719 – ident: e_1_3_2_14_2 doi: 10.1186/1742-4690-1-44 – ident: e_1_3_2_33_2 doi: 10.1016/j.virusres.2008.06.008 – ident: e_1_3_2_15_2 doi: 10.1099/vir.0.80449-0 – ident: e_1_3_2_29_2 doi: 10.1126/science.3014648 – ident: e_1_3_2_27_2 doi: 10.1016/0042-6822(83)90395-1 – ident: e_1_3_2_5_2 doi: 10.1038/nsmb1138 – ident: e_1_3_2_60_2 doi: 10.1093/nar/gkn805 – ident: e_1_3_2_10_2 doi: 10.1038/sj.emboj.7600491 |
| SSID | ssj0000331830 |
| Score | 2.3846064 |
| Snippet | The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep... ABSTRACT The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e000193 |
| SubjectTerms | binding sites biogenesis CD4-Positive T-Lymphocytes - virology Cells, Cultured crosslinking gene expression Gene Expression Regulation, Viral High-Throughput Nucleotide Sequencing HIV-1 - pathogenicity HIV-1 - physiology Host-Pathogen Interactions Human immunodeficiency virus 1 Humans macrophages Macrophages - virology messenger RNA microRNA MicroRNAs - chemistry MicroRNAs - genetics MicroRNAs - metabolism precipitin tests regulator genes RNA, Messenger - metabolism RNA, Viral - metabolism T-lymphocytes |
| SummonAdditionalLinks | – databaseName: Acceso a contenido Full Text - Doaj dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swELcmJKS9oAGDFTbkSRNPWPjbziMfQ2USPEwD8RYljgOV2qSi5YH_njunrVq0wcveIueSXM7n8519_h0hP7gOhbC-Zi5zhmmBdtCrkvEgMO1YV5nAA85X17Z_o3_dmbulUl-YE9bBA3eCO_Y1F9ELV_I60wILdAtX8wJeU4MrUUa0vjDnLQVTyQYr1FU-B9WU_nh0Omhx2yFTTKiVSShh9f_NwXydJ7k08Vx8Ihszj5GedJxukg-x2SLrXQ3J521yf9mw8ziePtA5vghtawpuHU2Lfd25BWzqX94yQXHdlZ7F4RDTT-kI0_F-X59QeN09Wj14umgq2mEat4_0KuLJ4MFkNPlMbi5-_jnrs1n1BBa0t1NmZYSwN1a2KJ2v0bCBEKX1GUQwEi5MbWRWQTgUgytEFU0JrkUB_ouryuBMVDtkrWmb-IVQiKmC565SMUhtgyyMynwEklAqySvfI0dzceZhBi2OFS6GeQoxpM9R-nmSfi5UjxwuyMcdpsa_CE-xbxZECIWdGkBB8pmC5O8pSI98n_dsDkMH90OKJrZPE_gAHh9VRrs3aJy2uDTGdY_sdtqwYEcqk4H3Cmy6FT1Z4Xf1TjN4SBDeyiptudv7Hz-4Tz7KVKMDszC_krXp41P8Bp7StDxIg-IFSRAOQw priority: 102 providerName: Directory of Open Access Journals |
| Title | In-Depth Analysis of the Interaction of HIV-1 with Cellular microRNA Biogenesis and Effector Mechanisms |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23592263 https://www.proquest.com/docview/1328543547 https://www.proquest.com/docview/1746354004 https://pubmed.ncbi.nlm.nih.gov/PMC3634607 https://doaj.org/article/8f01e817b0f941908217f0a074f163be |
| Volume | 4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfQEBIviG_Kx2QkxBMGf9t5QGgbjA6pe0AU9S1KHKer1Caj7ST233PnpIVOA_ESVcklcW2f_bvL3e8IecV1KIT1NXOZM0wLXAe9KhkPAsOOdZUJTHAendrhWH-ZmMlvSqG-A1fXmnZYT2q8nL_9-ePyAyj8-y4Bxr9bHM5a_KKQKYb1a2_CpuRQR0c90k-LssLJix4X2OM4c4AzNoybV5-ws0MlIv_r0OfVIMo_dqXju-RODyfpQTf-98iN2Nwnt7oCk5cPyPSkYR_j-fqMbshHaFtTwHw0eQK7pAY8NTz5zgRFpyw9ivM5xqbSBcbqfT09oPC4KS6JcHfRVLQjPG6XdBQxbXi2WqwekvHxp29HQ9aXVmBBe7tmVkawiWNli9L5Glc94UppfQbmjYQfpjYyq8BWisEVooqmBNxRALhxVRmcieoR2WvaJj4hFAyu4LmrVAxS2yALozIfQSSUSvLKD8ibTXfmoecdx_IX8zzZH9Ln2Pt56v1cqAF5vRU_7wg3_iZ4iGOzFUKe7HSiXU7zXu1yX3MR8b_xOtMCy7sLV_MCJmENQLSMA_JyM7I56BV-LCma2F6s4AWYW6qMdv-Qcdqi34zrAXnczYZtc6QyGUBbaKbbmSc77d290szOEr-3skpb7p7-x3ufkdsy1efACMznZG-9vIgvACWty_3kXYDj54nYT7rwC2fuDys |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In-Depth+Analysis+of+the+Interaction+of+HIV-1+with+Cellular+microRNA+Biogenesis+and+Effector+Mechanisms&rft.jtitle=mBio&rft.au=Whisnant%2C+Adam+W&rft.au=Bogerd%2C+Hal+P&rft.au=Flores%2C+Omar&rft.au=Ho%2C+Phong&rft.date=2013-05-01&rft.issn=2150-7511&rft.volume=4&rft.issue=2+p.e00193-13-e00193-13&rft_id=info:doi/10.1128%2FmBio.00193-13&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon |